• Product nameAnti-RNF13 antibody
    See all RNF13 primary antibodies
  • Description
    Goat polyclonal to RNF13
  • Tested applicationsSuitable for: IHC-P, WBmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Synthetic peptide: PNGERDYNIANTV, corresponding to C terminal amino acids 369-381 of Human RNF13.

  • Positive control
    • Human pancreas.
  • General notesPrincipal Names – RNF13; RZF; ring finger protein 13; RING zinc finger protein. Official Gene Symbol - RNF13. GenBank Accession Number – NP_009213. LocusLink ID - 11342 (human). Gene Ontology terms - peptidase activity; proteolysis and peptidolysis; nucleus.


  • FormLiquid
  • Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
  • Storage bufferPreservative: 0.02% Sodium Azide
    Constituents: 0.5% BSA, Tris buffered saline, pH 7.3
  • Concentration information loading...
  • PurityIgG fraction
  • Purification notesPurified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
  • ClonalityPolyclonal
  • IsotypeIgG
  • Research areas


Our Abpromise guarantee covers the use of ab4288 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
IHC-P Use at an assay dependent concentration. This antibodoidy stained islets but not in ducts and acini of Human normal pancreas. However, in pancreatic ductal adenocarcinoma staining was in the ducts and acini.
WB Use at an assay dependent dilution. Detects a band of approximately 60 kDa (predicted molecular weight: 43 kDa).Can be blocked with Human RNF13 peptide (ab23020).


  • FunctionE3 ubiquitin-protein ligase that may play a role in controlling cell proliferation.
  • Tissue specificityWidely expressed (at protein level). In normal pancreas, expressed in islets, but not in ducts, nor in acini (at protein level).
  • PathwayProtein modification; protein ubiquitination.
  • Sequence similaritiesContains 1 PA (protease associated) domain.
    Contains 1 RING-type zinc finger.
  • DomainThe RING-type zinc finger domain is required for E3 ligase activity.
  • Post-translational
  • Cellular localizationEndoplasmic reticulum membrane. Golgi apparatus membrane. Late endosome membrane. Lysosome membrane. Nucleus inner membrane. Under certain conditions, relocalizes to recycling endosomes and to the inner nuclear membrane.
  • Information by UniProt
  • Database links
  • Alternative names
    • E3 ubiquitin-protein ligase RNF13 antibody
    • FLJ93817 antibody
    • MGC13689 antibody
    • RING finger protein 13 antibody
    • Ring zinc finger protein antibody
    • RNF 13 antibody
    • Rnf13 antibody
    • RNF13_HUMAN antibody
    • RZF antibody
    see all

References for Anti-RNF13 antibody (ab4288)

This product has been referenced in:
  • Zhang Q  et al. RNF13: a novel RING-type ubiquitin ligase over-expressed in pancreatic cancer. Cell Res 19:348-57 (2009). WB, IHC-P ; Human . Read more (PubMed: 18794910) »

See 1 Publication for this product

Product Wall

Abcam has not validated the combination of species/application used in this Abreview.
Application Immunocytochemistry/ Immunofluorescence
Sample Human Cell (U2OS)
Permeabilization Yes - Triton
Specification U2OS
Blocking step BSA as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 2% · Temperature: 25°C
Fixative Formaldehyde

Miss. Chen Avrahami

Verified customer

Submitted May 16 2016

Thank you very much for contacting us regarding ab4288. I am very sorry to hear that you are experiencing difficulty with this antibody. Where did you place the tag on RNF13? It is possible that the tag is interfering with your ability to detect t...

Read More